Monthly Archives: September 2018

27 September 2018

Healthera – UCEF V investment

By |September 27th, 2018|

We are delighted to announce that the University of Cambridge Enterprise Fund V has invested in a £3m Series A financing round into Healthera, a provider of next-generation, pharmacy-integrated personal health management solutions.

Healthera connects patients to a platform of hundreds of pharmacies and NHS GPs, allowing them to order and track prescriptions, access clinical […]

Oxbotica – Parkwalk investment

By |September 19th, 2018|

Oxbotica, the autonomous vehicle software company, today announces the completion of a £14 million investment to support the next stage of its growth strategy. Funds have been secured from three leading investors: IP Group plc, Parkwalk Advisors and AXA XL (formerly XL Catlin).

The investment will be used to further accelerate Oxbotica’s sustained growth, which […]

AudioTelligence – University of Cambridge Enterprise Fund V investment

By |September 18th, 2018|

We have recently made an investment in a £3.1m seed funding round in to AudioTelligence for the University of Cambridge Enterprise Fund V.

AudioTelligence is delivering real-time audio processing technology for the enhancement of Automatic Speech Recognition (ASR) systems.

Speech control is being used increasingly in consumer electronics, with smart speakers being the world’s fastest-growing consumer […]

NuNano – University of Bristol Enterprise Fund II investment

By |September 18th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in NuNano.

NuNano specialise in the design of cantilever-based sensor devices and probes for atomic force microscopy. Microcantilevers are the simplest form of microelectromechanical systems (MEMS), which have come to prominence in the last decade or so. The basic […]

Exonate – University of Bristol Enterprise Fund II investment

By |September 17th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Exonate.

Exonate are developing a novel approach to modulating new vessel growth.  By controlling the balance of two contrasting forms of a protein called Vascular Endothelial Growth Factor (VEGF), they have demonstrated that they could not only treat models […]

Lettus Grow – University of Bristol Enterprise Fund II investment

By |September 1st, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Lettus Grow.

Lettus Grow is a Bristol-based company supported by the award winning SETSquared incubator and the Oracle Global Cloud Accelerator. The company has developed a novel irrigation system to increase productivity in food production, with early […]